person

ZAHER L.

Country
France
Department
Chirurgie générale, digestive et cancérologique

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
36
Sites with multiple studies

Has run more than one trial at 36 of 74 partner sites.

Specializations

Digestive Oncology

Clinical trial activity in digestive cancer focuses on resectable and advanced malignancies of the colon, rectum, stomach, pancreas, biliary tract, and esophagus, with additional interest in neuroendocrine tumors and complex postoperative settings.

  • Colorectal cancer
  • Pancreatic adenocarcinoma
  • Gastric and gastroesophageal junction cancer
  • Hepatocellular carcinoma
  • Esophageal carcinoma

Work in this area also includes surgical oncology for digestive tumors, with attention to treatment strategies for locally advanced, metastatic, and recurrent disease.

Breast and Gynecologic Cancer

The investigator is involved in studies on breast cancer across early, locally advanced, and metastatic settings, including hormone receptor-positive, HER2-negative, HER2-low, and triple-negative disease, as well as endometrial, ovarian, cervical, and uterine sarcoma malignancies.

  • Hormone receptor-positive breast cancer
  • Triple-negative breast cancer
  • Endometrial cancer
  • Ovarian cancer
  • Cervical cancer

Therapeutic interests extend to biomarker-defined disease, postoperative risk reduction, and management of recurrent or unresectable gynecologic cancers.

Thoracic and Head and Neck Oncology

Research involvement includes non-small cell lung cancer, small cell lung cancer, and head and neck squamous cell carcinoma, with coverage of resected, locally advanced, and metastatic presentations.

  • Non-small cell lung cancer
  • Small cell lung cancer
  • Head and neck squamous cell carcinoma
  • Melanoma
  • Cutaneous squamous cell carcinoma

The clinical focus also includes melanoma and other skin cancers, reflecting interest in advanced solid tumors requiring systemic and perioperative treatment approaches.

Urologic and Renal Malignancies

Investigational activity covers prostate cancer, renal cell carcinoma, and urothelial carcinoma, with attention to localized, recurrent, and metastatic disease states.

  • Prostate cancer
  • Renal cell carcinoma
  • Urothelial carcinoma
  • Bladder cancer
  • Kidney cancer

These studies also address high-risk disease biology and treatment optimization in genitourinary oncology.

Hematology, Immunology, and Supportive Care

The investigator participates in trials spanning acute leukemia, lymphoma, myelodysplastic syndromes, and multiple myeloma, alongside immune-mediated disorders such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, and multiple sclerosis.

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Diffuse large B-cell lymphoma
  • Inflammatory bowel disease
  • Cardiovascular disease

Additional research interests include cardiovascular prevention, stroke, thrombosis, and postoperative complications, linking oncologic care with broader internal medicine and perioperative support.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.